Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice

scientific article

Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1030370653
P356DOI10.1186/S13287-016-0395-Z
P3181OpenCitations bibliographic resource ID2756225
P932PMC publication ID5084318
P698PubMed publication ID27793190

P2093author name stringJun Xu
Wei Lu
Yan Li
Cheng Chen
Limei Zhu
Yan Shao
Weiqing Shi
XiaoDong Han
P2860cites workAvian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human populationQ21245109
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genesQ21559413
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studiesQ28260818
Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6Q28566510
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1Q28757126
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 productionQ29619807
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.Q30327047
Influenza A (H5N1) in Hong Kong: an overview.Q30331157
Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infectionQ30409253
Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infectionQ30409432
Clinical research during a public health emergency: a systematic review of severe pandemic influenza management.Q30427085
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case seriesQ33360515
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.Q34143724
Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cellsQ34328051
First reported detection of a low pathogenicity avian influenza virus subtype H9 infection in domestic fowl in EnglandQ34403434
Different environmental drivers of highly pathogenic avian influenza H5N1 outbreaks in poultry and wild birdsQ34544962
Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in TunisiaQ34551481
Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cellsQ34714698
Mechanisms of submucosal gland morphogenesis in the airway.Q35060126
Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virusQ35363365
Chemokines in acute respiratory distress syndromeQ35980338
Innate immunity to H5N1 influenza viruses in humansQ36482747
Seroepidemiological evidence of avian influenza A virus transmission to pigs in southern ChinaQ36559128
Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011.Q36584392
Gene-modified mesenchymal stem cells protect against radiation-induced lung injuryQ36673719
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.Q36749464
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applicationsQ37007214
Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatosesQ37921773
Lung injury in preterm neonates: the role and therapeutic potential of stem cellsQ37991744
Cellular and molecular interactions of mesenchymal stem cells in innate immunityQ38059340
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testingQ38073092
Comparison of serum treatments to remove nonspecific inhibitors from chicken sera for the hemagglutination inhibition test with inactivated H5N1 and H9N2 avian Influenza A virus subtypesQ38460488
Clinical features of avian influenza in Egyptian patientsQ38881737
The pathogenicity and host immune response associated with H5N1 highly pathogenic avian influenza virus in quailQ42285154
Antigenic and genetic characterization of a European avian-like H1N1 swine influenza virus from a boy in China in 2011.Q43171592
Human infection with influenza H9N2.Q43209306
Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducksQ45352670
H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory responseQ45371027
Identification of potential risk factors associated with highly pathogenic avian influenza subtype H5N1 outbreak occurrence in Lagos and Kano States, Nigeria, during the 2006-2007 epidemics.Q46477204
A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.Q53107971
Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in ratsQ83991066
Human embryonic stem cell-derived hematopoietic cells maintain core epigenetic machinery of the polycomb group/Trithorax Group complexes distinctly from functional adult hematopoietic stem cellsQ84576581
Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cellsQ84824101
Spontaneous breathing with biphasic positive airway pressure attenuates lung injury in hydrochloric acid-induced acute respiratory distress syndromeQ87657655
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectavian influenzaQ43987
acute lung injuryQ4677935
P304page(s)159
P577publication date2016-10-28
P1433published inStem Cell Research & TherapyQ14390536
P1476titleMesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice
P478volume7

Reverse relations

cites work (P2860)
Q91922933A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Q99401090COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy
Q90536394Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury
Q91707486Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
Q59358581EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury
Q38901248Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value.
Q55280335IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation.
Q90074681MSC Based Therapies-New Perspectives for the Injured Lung
Q47548197Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model
Q37649042Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality.
Q94518099Mesenchymal stem cells as a potential therapy for COVID-19
Q94559488Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases
Q96138639Novel therapeutic approaches for treatment of COVID-19
Q60938728TLR3 Regulated Poly I:C-Induced Neutrophil Extracellular Traps and Acute Lung Injury Partly Through p38 MAP Kinase
Q47554935The role of adjuvant immunomodulatory agents for treatment of severe influenza
Q99571376The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Q64106024The therapeutic effects of bone marrow-derived mesenchymal stromal cells in the acute lung injury induced by sulfur mustard

Search more.